Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (Nature Biomedical Engineering, (2021), 5, 9, (983-997), 10.1038/s41551-021-00791-0)

Jung Seok Lee, Patrick Han, Rabib Chaudhury, Shihan Khan, Sean Bickerton, Michael D. McHugh, Hyun Bong Park, Alyssa L. Siefert, Gerald Rea, José M. Carballido, David A. Horwitz, Jason Criscione, Karlo Perica, Robert Samstein, Ragy Ragheb, Dongin Kim, Tarek M. Fahmy

Research output: Contribution to journalComment/debate

1 Scopus citations

Abstract

In the version of this Article initially published, there was an error in the list of author names. Ragy Ragheb’s last name was misspelt in the original as Rageb. The error has been corrected in the online version of the paper.

Original languageEnglish
Pages (from-to)1403
Number of pages1
JournalNature Biomedical Engineering
Volume5
Issue number11
DOIs
StatePublished - Nov 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Author Correction: Metabolic and immunomodulatory control of type 1 diabetes via orally delivered bile-acid-polymer nanocarriers of insulin or rapamycin (Nature Biomedical Engineering, (2021), 5, 9, (983-997), 10.1038/s41551-021-00791-0)'. Together they form a unique fingerprint.

Cite this